Abstract
BackgroundThe association between obesity and outcomes in patients receiving programmed death-1/programmed death ligand-1 (PD-L1) checkpoint inhibitors has already been confirmed in pre-treated non-small cell lung cancer (NSCLC) patients, regardless of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have